| Mark D Hennessy, MD | |
|
1924 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920-1511 | |
| (865) 305-8888 | |
| (865) 305-2514 |
| Full Name | Mark D Hennessy |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 1924 Alcoa Hwy, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194710467 | NPI | - | NPPES |
| 3069396 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | MD 23608 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| High Risk Obstetrical Consultants, Pllc | 8729137021 | 8 |
News Archive
Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.
› Verified 6 days ago
| Entity Name | University Of Tennessee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295751386 PECOS PAC ID: 3072421213 Enrollment ID: O20040110000145 |
News Archive
Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.
› Verified 6 days ago
| Entity Name | Regional Obstetrical Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861485146 PECOS PAC ID: 1153211743 Enrollment ID: O20040317001170 |
News Archive
Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.
› Verified 6 days ago
| Entity Name | High Risk Obstetrical Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770724676 PECOS PAC ID: 8729137021 Enrollment ID: O20161116003031 |
News Archive
Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark D Hennessy, MD 1930 Alcoa Hwy, Ste 435, Knoxville, TN 37920-1520 Ph: (865) 305-8888 | Mark D Hennessy, MD 1924 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920-1511 Ph: (865) 305-8888 |
News Archive
Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.
In the first real-world trial of the impact of patient-controlled access to electronic medical records, almost half of the patients who participated withheld clinically sensitive information in their medical records from some or all of their health care providers.
Santhera Pharmaceuticals and Ipsen today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic alpha-2 receptor) for territories outside of North America and Japan. This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease.
Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability.
› Verified 6 days ago
Dr. Periclis Roussis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-331-2020 Fax: 865-331-2019 | |
Dr. George Walton Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-541-1975 Fax: 865-541-1976 | |
Dr. Roy Cox Broady, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th Street, Suite 509, Knoxville, TN 37916 Phone: 865-524-3208 Fax: 865-522-4322 | |
Courtney Roth, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920 Phone: 865-305-5622 | |
Dr. Lynlee Marie Wolfe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1925 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920 Phone: 865-305-8888 | |
Jeffrey A Keenan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11126 Kingston Pike, Knoxville, TN 37934 Phone: 865-777-0088 Fax: 865-777-2015 | |
Kristopher J. Kimball, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920 Phone: 865-305-5622 Fax: 865-305-4580 |